- Tirilazad
drugbox
IUPAC_name = ("8S,10S,13S,14S,16R,17S")-17- [2- [4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl] acetyl] -10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta [a] phenanthren-3-one
CAS_number = 110101-66-1
ATC_prefix = N07
ATC_suffix = XX01
PubChem = 104903
DrugBank =
C=38|H=52|N=6|O=2
molecular_weight = 624.859 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =Tirilazad is a drug proposed for use in the treatment of
stroke , though results so far have been mixed. [cite web |url=http://www.cochrane.org/reviews/en/ab002087.html |title=Tirilazad for acute ischaemic stroke |accessdate=2007-07-28 |format= |work=]References
Wikimedia Foundation. 2010.